openPR Logo
Press release

Animal Biotechnology Market to Reach USD 49.02 Billion by 2030, Growing at 9.9% CAGR

10-24-2025 08:04 AM CET | Health & Medicine

Press release from: DataM Intelligence

Animal Biotechnology Market

Animal Biotechnology Market

According to DataM Intelligence, the global animal biotechnology market was valued at USD 28.11 billion in 2024 and is projected to reach USD 49.02 billion by 2030, expanding at a CAGR of 9.9% from 2025 to 2030. The market is witnessing accelerating growth due to increasing R&D investments, rising disease prevalence among animals, evolving regulatory frameworks, and sustained support from industry participants. Animal biotechnology continues to play a pivotal role in advancing animal health, food security, and veterinary drug innovation through biologics, vaccines, molecular diagnostics, and genetic engineering techniques.

The growing incidence of conditions such as cancer, avian influenza, and foot-and-mouth disease has intensified the need for robust diagnostic, preventive, and therapeutic solutions. North America led the global market in 2024 owing to mature R&D infrastructure, while China is forecast to register the fastest CAGR from 2025 to 2030, driven by biotech innovation and government support. The dominance of the biologics segment, which accounted for USD 9.73 billion in 2024, reflects the market's shift toward preventive healthcare and advanced biologic therapies that enhance animal immunity and productivity.

Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/animal-biotechnology-market?utm_source=OpenPR&utm_campaign=Onkar

Key Highlights from the Report

➤ Global animal biotechnology market to reach USD 49.02 billion by 2030 at a 9.9% CAGR.
➤ Biologics led the market with USD 9.73 billion in 2024 and remain the fastest-growing segment.
➤ North America dominated with a 34% revenue share in 2024, driven by high veterinary R&D investment.
➤ China projected to exhibit the highest growth rate over the forecast period.
➤ Laboratories held 35.24% market share, underscoring their leading role in diagnostics and R&D research.
➤ Rapid innovation in vaccines, stem-cell therapies, and monoclonal antibodies drives industry adoption.

Market Segmentation

The biologics segment accounted for the largest share of over 31.5% in 2024, supported by rising use of vaccines, mAbs, and gene-based therapies for preventive and therapeutic applications. For instance, Yale University's 2024 canine cancer vaccine improved tumor response and increased survival rates by 25 percentage points compared to traditional treatments. Similarly, Washington State University's Feed the Future Veterinary Vaccine Lab launched in Africa aims to expand vaccine coverage in livestock populations.

By application, the preventive care category dominated in 2024, driven by the pet humanization trend and expanding veterinary vaccinations. Governments and private organizations are promoting animal care initiatives that emphasize regular preventive health programs for pets and livestock. Moreover, the product R&D segment is growing rapidly, fueled by active investments from universities and biotech firms focused on genetic research and advanced diagnostics such as UC Davis's Veterinary Genetics Laboratory expansion initiative.

In terms of animal type, livestock led the market due to the growing demand for safe and sustainable animal-derived food products, while companion animals are expected to experience the highest growth rate, influenced by innovations in pain management, stem-cell therapy, and personalized nutrition.

Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/animal-biotechnology-market?utm_source=OpenPR&utm_campaign=Onkar

Regional Insights

North America held the largest market share, exceeding 34% in 2024, underpinned by strong veterinary infrastructure, R&D initiatives, and corporate expansions. For instance, Elanco Animal Health invested USD 130 million in expanding its Kansas-based facility to strengthen biologics manufacturing capabilities. Regulatory advancements, such as the U.S. FDA's framework updates for heritable genomic alterations in animals, further support innovation and product approvals.

Europe is witnessing rapid growth through consolidation and R&D collaborations. Companies like Ceva Santé Animale and Dechra Pharmaceuticals have prioritized acquisitions-such as Ceva's acquisition of Scout Bio-to enhance capabilities in monoclonal antibodies and gene therapies. UK-based collaborations continue to strengthen biotherapeutic development for chronic veterinary diseases.

Asia Pacific is projected to record the highest CAGR, led by China, India, and Japan. Factors such as a growing pet population, government biotech initiatives, and increased protein consumption are accelerating market expansion. For example, China's Ringbio launched an advanced ELISA kit targeting Brucella infections, while India's NIAB-Pirbright collaboration strengthened zoonotic research and local vaccine production.

In Latin America, nations like Brazil and Argentina are fostering innovations through public-private collaborations, such as Biogénesis Bagó's USD 30 million vaccine facility expansion, while in the Middle East and Africa (MEA), Israel's Remilk and South Africa's Afrigen Biologics are pioneering cost-effective biotech and mAb solutions using novel production techniques like transgenic goat milk.

Market Dynamics

Market Drivers

Rising investments in veterinary biotechnology, a surge in companion animal adoption, and global efforts to combat animal-borne diseases drive demand for biologics, diagnostics, and genetic innovations. Increasing focus on food security and zoonotic disease prevention further enhances biotechnology adoption across livestock and companion animal sectors.

Market Restraints

High development costs, long regulatory approval cycles, and limited access to advanced laboratory infrastructure in developing regions constrain market growth. Additionally, a shortage of skilled professionals in veterinary biotechnology continues to challenge full-scale commercialization.

Market Opportunities

Rising demand for next-generation vaccines, gene-editing tools, and cell therapies presents significant opportunities. Collaborative R&D initiatives and global alliances are fostering faster drug approvals. Government-backed initiatives, such as GMP standardization for veterinary APIs, provide long-term growth potential by regulating safety, efficacy, and manufacturing consistency.

Purchase This Exclusive Report at Just USD 5368 Only: https://www.datamintelligence.com/buy-now-page?report=animal-biotechnology-market?utm_source=OpenPR&utm_campaign=Onkar

Reasons to Buy the Report

✔ Comprehensive analysis of key trends shaping global animal biotechnology innovation.
✔ Insight into regional market dynamics and emerging opportunities.
✔ Strategic breakdown of biologics, diagnostics, and R&D application segments.
✔ Evaluation of competitive strategies among leading biotechnology firms.
✔ Identification of high-growth regions and future investment hotspots.

Frequently Asked Questions (FAQs)

◆ How big is the global animal biotechnology market in 2024?
◆ What is the projected CAGR for the animal biotechnology market through 2030?
◆ Which segment dominates the global animal biotechnology industry?
◆ Which region will record the fastest growth in the animal biotechnology market?
◆ Who are the key players shaping the global animal biotechnology landscape?

Company Insights

Zoetis

Boehringer Ingelheim

Merck & Co., Inc.

Virbac

Elanco Animal Health

IDEXX Laboratories

Dechra Pharmaceuticals

Heska Corporation

Indian Immunologicals Ltd

Hester Biosciences Pvt. Ltd

Biogénesis Bagó

Recent Developments

In September 2024, Zoetis expanded its Hyderabad vaccine manufacturing facility to increase production of advanced biologics and diagnostic tools for livestock and pet health.
In August 2024, Anvive Lifescience Inc. secured a USD 33 million contract with the U.S. NIH to develop a vaccine for Valley Fever in dogs, highlighting ongoing innovation in zoonotic disease prevention.

In September 2024, Bioassay GmbH obtained GMP certification for its veterinary bioanalytical testing plant in Germany, reinforcing compliance with new manufacturing quality standards.

Conclusion

The global animal biotechnology market is poised for transformative growth, backed by scientific innovation, increasing global disease outbreaks, and expanding collaborations across borders. With a potential market valuation of USD 49.02 billion by 2030, the sector's trajectory is defined by its pivotal role in ensuring animal health, sustainable agriculture, and biosecurity. The dominance of biologics, ongoing advancements in genetic engineering, and the rise of veterinary startups are reshaping the future of animal biotechnology worldwide.

Contact Us

Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com

About Us

DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Animal Biotechnology Market to Reach USD 49.02 Billion by 2030, Growing at 9.9% CAGR here

News-ID: 4237271 • Views:

More Releases from DataM Intelligence

Nanocomposites Market to Hit USD 15.34 Billion by 2030 | DataM Intelligence
Nanocomposites Market to Hit USD 15.34 Billion by 2030 | DataM Intelligence
Expanding Applications Across Electronics and Automotive Fuel Market Growth The global Nanocomposites Market was valued at USD 8.28 billion in 2023 and is projected to reach USD 15.34 billion by 2030, growing at a robust CAGR of 8.7% (2024-2030), according to DataM Intelligence. The surge in demand for nanocomposites can be attributed to their growing applications across packaging, automotive, defense, and aerospace industries, where superior strength, corrosion resistance, and thermal stability
Recycled Carbon Fiber Market to Reach USD 0.31 Billion by 2030, Growing at 13.3% CAGR
Recycled Carbon Fiber Market to Reach USD 0.31 Billion by 2030, Growing at 13.3% …
The global recycled carbon fiber market was valued at approximately USD 0.16 billion in 2025 and is projected to reach USD 0.31 billion by 2030, growing at a significant CAGR of 13.3% from 2025 to 2030, per insights from DataM Intelligence and corroborated by recent industry analyses. This growth is primarily driven by increasing global emphasis on sustainability and circular economy initiatives across industries, compelling manufacturers to adopt eco-friendly materials
Industrial Cybersecurity Market to Surpass USD 135.1 Billion by 2029 at 9.8% CAGR
Industrial Cybersecurity Market to Surpass USD 135.1 Billion by 2029 at 9.8% CAG …
According to DataM Intelligence, the global industrial cybersecurity market was valued at USD 84.54 billion in 2024 and is forecasted to reach USD 135.11 billion by 2029, expanding at a CAGR of 9.8% from 2025 to 2029. This robust growth is primarily driven by the rising integration of IoT, AI, and Industry 4.0 technologies in industrial systems and the escalating incidence of sophisticated cyberattacks on critical infrastructure. As industrial operations
Electric Vehicle Insulation Market to Surpass USD 5.4 Billion by 2027 at 19.5% CAGR
Electric Vehicle Insulation Market to Surpass USD 5.4 Billion by 2027 at 19.5% C …
According to DataM Intelligence, the global electric vehicle insulation market was valued at USD 1.3 billion in 2019 and is projected to reach USD 5.4 billion by 2027, growing at a CAGR of 19.5% from 2020 to 2027. The market expansion is attributed to favorable government initiatives promoting green transportation, growing EV adoption, and increasing emphasis on energy efficiency and passenger safety. The surge in hybrid and battery-powered vehicles highlights

All 5 Releases


More Releases for USD

Chlorella Market Reach USD 465.85 Million USD by 2030
Market Growth Fueled by Increased Adoption of Plant-Based Proteins and Health Supplements Global Chlorella Market size was valued at USD 303.75 Mn. in 2023 and the total Chlorella revenue is expected to grow by 6.3 % from 2024 to 2030, reaching nearly USD 465.85 Mn. . The growth of the market is majorly due to increase in the consumer awareness about health, the inclination towards plant-based food such as chlorella and
Bamboo Clothing Market: USD 1.83B to USD 3.27B by 2030
Bamboo Clothing Market Poised for Robust Growth with Sustainability and Eco-Friendly Trends Driving Demand The global bamboo clothing market is experiencing substantial growth, spurred by a significant shift towards sustainable fashion and eco-friendly materials. As consumers become increasingly conscious of their environmental impact, bamboo fabric-known for its natural, biodegradable properties-is gaining popularity in the fashion industry. This market is expected to continue its upward trajectory, driven by rising demand for eco-conscious
Biometrics Market: "Biometrics: USD 34.3B to USD 112.4B by 2031"
Biometrics Market Market Scope: Key Insights : Biometrics Market size was valued at USD 34.3 billion in 2022 and is poised to grow from USD 39.1 billion in 2023 to USD 112.4 billion by 2031, growing at a CAGR of 14.1% during the forecast period (2024-2031). Discover Your Competitive Edge with a Free Sample Report :https://www.skyquestt.com/sample-request/biometrics-market Access the full 2024 Market report for a comprehensive understanding @https://www.skyquestt.com/report/biometrics-market In-Depth Exploration of the global Biometrics
Advanced (3D/4D) Visualization Systems Market Size, Trends, Growth, Share to sur …
Fatpos Global has carefully studied specific areas, such as application and product type, in the global Advanced (3D/4D) Visualization Systems Market research study. During the predicted period of 2022 to 2032, each kind gives data on sales. The Advanced (3D/4D) Visualization Systems Market analysis examines into the characteristics and financials of the leading participants. As per the analysis research report, the Advanced (3D/4D) Visualization Systems Market to
$100,000,000 USD job contract for travel - $3,000,000 USD referral commission.
Khoja Consultants invites companies, teams or venture capitalists for a $100,000,000 USD contract for travel. The selected company will be providing all accommodations and expenses for a 6-month long business trip around the world. Khoja Consultants expects five-star treatment including close security with private planes, hotels, secured vehicles and helicopters if necessary. More details on the job contract and application are provided at - www.KhojaConsultants.com. There is a $3,000,000
IOT Solutions Market worth USD 553.9 million USD by 2026
"The global IoT solutions market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cybersecurity as a service market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa." These days many businesses are adopting a market research report